F. van Valen
- Oncology top 5%
- Bone health and treatments 5
- Cancer Research top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses 5
- interferon and immune responses 4
-
- Sarcoma Diagnosis and Treatment 14
- Molecular Biology top 10%
- Cell death mechanisms and regulation 6
- Chemical Synthesis and Analysis 4
-
- Neuroblastoma Research and Treatments 6
-
- Neuropeptides and Animal Physiology 5
- Co-authors
- Barbara Dockhorn‐DworniczakKlaus‐Michael DebatinSimone FuldaÉric MeyerH. JürgensW. WinkelmannWinfried WinkelmannHeribert Jürgens
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Cancer Research and Clinical Oncology (6 papers)Biochemical and Biophysical Research Communications (4 papers)International Journal of Cancer (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
F. van Valen
47 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Oncology 491
- Cancer Research 221
- Immunology 272
- Pulmonary and Respiratory Medicine 420
- Molecular Biology 844
Countries citing papers authored by F. van Valen
This map shows the geographic impact of F. van Valen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. van Valen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. van Valen more than expected).
Fields of papers citing papers by F. van Valen
This network shows the impact of papers produced by F. van Valen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. van Valen. The network helps show where F. van Valen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. van Valen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 39 | |
| 2 | 2005 | 33 | |
| 3 | 2004 | 56 | |
| 4 | 2003 | 39 | |
| 5 | 2002 | 2 | |
| 6 | 2002 | 21 | |
| 7 | 2001 | 26 | |
| 8 | 2001 | 70 | |
| 9 | 2001 | 12 | |
| 10 | 2001 | 324 | |
| 11 | 2000 | 49 | |
| 12 | 1997 | 13 | |
| 13 | 1994 | 49 | |
| 14 | 1994 | 5 | |
| 15 | 1993 | 25 | |
| 16 | 1992 | 23 | |
| 17 | 1991 | 24 | |
| 18 | 1989 | 6 | |
| 19 | 1988 | 10 | |
| 20 | 1988 | 6 |
About F. van Valen
F. van Valen is a scholar working on Oncology, Applied Microbiology and Biotechnology, Immunology and Allergy, Immunology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Cell death mechanisms and regulation (6 papers), Neuroblastoma Research and Treatments (6 papers), Immunotherapy and Immune Responses (5 papers), Neuropeptides and Animal Physiology (5 papers), Bone health and treatments (5 papers), interferon and immune responses (4 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Oncology (491 citations), Cancer Research (221 citations), Immunology (272 citations), Pulmonary and Respiratory Medicine (420 citations) and Molecular Biology (844 citations). F. van Valen has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Barbara Dockhorn‐Dworniczak, Klaus‐Michael Debatin, Simone Fulda, Éric Meyer, H. Jürgens, W. Winkelmann, Winfried Winkelmann, Heribert Jürgens, Christopher Poremba and Joachim Boos. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Biochemical and Biophysical Research Communications, International Journal of Cancer, FEBS Letters and Planta Medica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.